PTC
MDT icon

Philadelphia Trust Company’s Medtronic MDT Stock Holding History

Philadelphia Trust Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Sell
23,994
-1,596
-6% -$153K 0.15% 82
2025
Q4 		$2.46M Sell
25,590
-658
-3% -$63.9K 0.17% 77
2025
Q3 		$2.5M Sell
26,248
-22,356
-46% -$2.06M 0.18% 75
2025
Q2 		$4.24M Sell
48,604
-79,982
-62% -$6.78M 0.33% 57
2025
Q1 		$11.6M Sell
128,586
-58,423
-31% -$5.23M 0.99% 24
2024
Q4 		$14.9M Sell
187,009
-63,336
-25% -$5.48M 1.1% 24
2024
Q3 		$22.5M Buy
250,345
+2,406
+1% +$202K 1.64% 17
2024
Q2 		$19.5M Sell
247,939
-433
-0.2% -$35.5K 1.52% 18
2024
Q1 		$21.6M Buy
248,372
+3,961
+2% +$338K 1.74% 15
2023
Q4 		$20.1M Sell
244,411
-2,471
-1% -$188K 1.89% 14
2023
Q3 		$19.3M Sell
246,882
-13,574
-5% -$1.14M 1.99% 13
2023
Q2 		$22.9M Buy
260,456
+5,052
+2% +$435K 2.17% 11
2023
Q1 		$20.6M Buy
255,404
+30,852
+14% +$2.51M 2.1% 12
2022
Q4 		$17.5M Sell
224,552
-17,299
-7% -$1.4M 1.87% 15
2022
Q3 		$19.5M Buy
241,851
+1,425
+0.6% +$128K 2.21% 14
2022
Q2 		$21.6M Buy
240,426
+43,144
+22% +$4.37M 2.22% 13
2022
Q1 		$21.9M Buy
197,282
+9,456
+5% +$999K 1.73% 15
2021
Q4 		$19.4M Sell
187,826
-48,090
-20% -$5.57M 1.41% 21
2021
Q3 		$29.6M Sell
235,916
-9,829
-4% -$1.27M 2.18% 16
2021
Q2 		$30.5M Sell
245,745
-1,464
-0.6% -$184K 2.1% 17
2021
Q1 		$29.2M Sell
247,209
-1,618
-0.7% -$190K 2.25% 14
2020
Q4 		$29.1M Buy
248,827
+890
+0.4% +$98K 2.38% 12
2020
Q3 		$25.8M Buy
247,937
+274
+0.1% +$27.5K 2.48% 12
2020
Q2 		$22.7M Sell
247,663
-382
-0.2% -$36.6K 2.39% 13
2020
Q1 		$22.4M Sell
248,045
-4,746
-2% -$505K 2.82% 11
2019
Q4 		$28.7M Sell
252,791
-5,192
-2% -$570K 2.46% 9
2019
Q3 		$28M Sell
257,983
-22,612
-8% -$2.36M 2.6% 7
2019
Q2 		$27.3M Sell
280,595
-891
-0.3% -$81.3K 2.41% 10
2019
Q1 		$25.6M Buy
281,486
+124,705
+80% +$11.2M 2.26% 11
2018
Q4 		$14.3M Sell
156,781
-1,075
-0.7% -$100K 1.52% 20
2018
Q3 		$15.5M Sell
157,856
-780
-0.5% -$72.1K 1.27% 23
2018
Q2 		$13.6M Buy
158,636
+8,721
+6% +$728K 1.21% 24
2018
Q1 		$12M Sell
149,915
-6,160
-4% -$508K 1% 31
2017
Q4 		$12.6M Buy
156,075
+2,601
+2% +$208K 0.99% 32
2017
Q3 		$11.9M Sell
153,474
-5,894
-4% -$489K 0.98% 34
2017
Q2 		$14.1M Sell
159,368
-10,756
-6% -$907K 1.2% 32
2017
Q1 		$13.7M Sell
170,124
-32,775
-16% -$2.56M 1.13% 34
2016
Q4 		$14.5M Buy
202,899
+23,420
+13% +$1.84M 1.15% 39
2016
Q3 		$15.5M Sell
179,479
-15,987
-8% -$1.39M 1.34% 30
2016
Q2 		$17M Sell
195,466
-57,390
-23% -$4.64M 1.47% 28
2016
Q1 		$19M Buy
252,856
+218,490
+636% +$16.5M 1.62% 22
2015
Q4 		$2.59M Sell
34,366
-700
-2% -$52.7K 0.22% 73
2015
Q3 		$2.35M Buy
35,066
+32,458
+1,245% +$2.39M 0.21% 73
2015
Q2 		$35.2K Buy
+2,608
New +$199K 0.13% 96
2014
Q4 		– Sell
-37,191
Closed -$2.3M – 160
2014
Q3 		$2.3M Sell
37,191
-720
-2% -$45.8K 0.14% 75
2014
Q2 		$2.42M Sell
37,911
-2,103
-5% -$128K 0.15% 73
2014
Q1 		$2.46M Sell
40,014
-1,618
-4% -$94.2K 0.16% 65
2013
Q4 		$2.39M Sell
41,632
-3,196
-7% -$181K 0.15% 69
2013
Q3 		$2.39M Sell
44,828
-968
-2% -$52.1K 0.16% 73
2013
Q2 		$2.36M Buy
+45,796
New +$2.26M 0.18% 73

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Philadelphia Trust Company's MDT Position: Q1 2026 in Review

Philadelphia Trust Company reduced its Medtronic (MDT) stake by 6.2% in Q1 2026, selling an estimated $153K and leaving 23,994 shares worth $2.08M. The position accounts for 0.15% of the portfolio, ranked #82.

Philadelphia Trust Company first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $30.5M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Philadelphia Trust Company held 23,994 shares of Medtronic worth $2.08M as of Q1 2026.
  • Philadelphia Trust Company sold 1,596 Medtronic shares in Q1 2026, an estimated $153K.
  • Medtronic made up 0.15% of Philadelphia Trust Company's portfolio in Q1 2026, its #82 holding.
  • Philadelphia Trust Company first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
  • Philadelphia Trust Company's Medtronic position peaked at $30.5M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.